Title | A newly described cutaneous reaction at sites of insulin pump use in a child with Type 1 diabetes. |
Publication Type | Journal Article |
Year of Publication | 2021 |
Authors | Perez VA, Husain S, Magro CM, Strom MA, Williams KM, Levin LE |
Journal | Pediatr Dermatol |
Volume | 38 |
Issue | 1 |
Pagination | 239-241 |
Date Published | 2021 Jan |
ISSN | 1525-1470 |
Keywords | Blood Glucose, Blood Glucose Self-Monitoring, Child, Diabetes Mellitus, Type 1, Humans, Hypoglycemic Agents, Insulin Infusion Systems |
Abstract | Continuous subcutaneous insulin infusion (CSII), or insulin pumps, with or without continuous glucose monitoring (CGM) devices have become the standard of care for patients with type 1 diabetes. While increasingly popular, a wide range of reported skin reactions to CSII and CGM devices was found. We present this case of a pyogenic granuloma-like neutrophilic and granulomatous response to an insulin pump to increase awareness of a previously uncharacterized cutaneous adverse reaction at insulin pump infusion sites. |
DOI | 10.1111/pde.14438 |
Alternate Journal | Pediatr Dermatol |
PubMed ID | 33169884 |
Related Faculty:
Cynthia M. Magro, M.D.